| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/15/1992 | CN1062732A Optically-active thiazoloisoindolinone derivatives with antiviral action |
| 07/15/1992 | CA2099772A1 Anti-hiv activity of liposomal nystatin and amphotericin b |
| 07/14/1992 | US5130241 Clavam derivatives and its enzymatic preparation |
| 07/14/1992 | CA1305141C2 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent |
| 07/14/1992 | CA1305140C2 Protected n -9-(1,3-dihydroxy-2-propoxymethyl) guanine derivatives |
| 07/14/1992 | CA1305139C 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent |
| 07/14/1992 | CA1305138C Antiviral acyclic nucleoside derivatives and their preparation |
| 07/14/1992 | CA1305137C Ring open nucleoside analogues |
| 07/14/1992 | CA1305081C Recombinant herpes simplex viruses, vaccines and methods |
| 07/12/1992 | WO1992012235A1 FLAGELLA-LESS $i(BORRELIA) |
| 07/12/1992 | CA2100244A1 Flagella-less borrelia |
| 07/11/1992 | CA2058699A1 Trifluoromethyl 1-carba(1-dethia)cephems |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011370A2 Polypeptides derived from proteins of the hepatitis c virus |
| 07/09/1992 | WO1992011368A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 07/09/1992 | WO1992011367A2 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | WO1992011366A1 Cloning and expression of a protein antigen of toxoplasma gondii |
| 07/09/1992 | WO1992011361A1 Improved vaccines |
| 07/09/1992 | WO1992011291A1 Vaccines based on hepatitis b surface antigen |
| 07/09/1992 | WO1992011288A1 Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 07/09/1992 | WO1992011023A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| 07/09/1992 | WO1992011015A1 Use of host cell phospholipids for inhibiting microbial colonization |
| 07/09/1992 | WO1992010936A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 07/09/1992 | CA2098845A1 Cloning and expression of protein antigen of toxoplasma gondii |
| 07/09/1992 | CA2098733A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | CA2098719A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| 07/09/1992 | CA2098598A1 Adhesin-oligosaccharide conjugate vaccine for haemophilus influenzae |
| 07/08/1992 | EP0494078A1 Amides of antibiotic ge 2270 factors |
| 07/08/1992 | EP0493770A2 Antiherpes compositions |
| 07/08/1992 | EP0493767A2 Synergistic combination for treating herpes infections |
| 07/08/1992 | EP0493722A1 2-Halogeno-oxetanocin A and phosphoric ester thereof |
| 07/08/1992 | EP0493608A1 Quinolonecarboxylic acid derivative |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | EP0469036A4 Composition and treatment with biologically active peptides and antibiotic |
| 07/08/1992 | EP0455719A4 Composition and treatment with peptide combinations |
| 07/08/1992 | CN1062536A Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/08/1992 | CN1062535A Derivatives of 10, 11, 12, 13-tetrahydrodesmycosin, processes for preparation, and use thereof in pharmaceuticals |
| 07/08/1992 | CN1062528A Benzodiazepinone |
| 07/08/1992 | CA2033737A1 Drug for fighting aids and other viral infections |
| 07/07/1992 | US5128479 Oxidized diphenylheteroalkanes |
| 07/07/1992 | US5128458 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| 07/07/1992 | US5128344 Sampangine and derivatives useful as an antifungal agent |
| 07/07/1992 | US5128335 Antibiotics |
| 07/07/1992 | US5128119 Methods for technetium/rhenium labeling of f(ab1)2 fragments |
| 07/07/1992 | CA1304753C Iodonium ylide antimicrobial compounds |
| 07/07/1992 | CA1304738C 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo- quinoline-3-carboxylic acids, processes for their preparation and antibacterial agents containing these compounds |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/01/1992 | EP0492841A1 Anti-herpes castanospermine esters |
| 07/01/1992 | EP0492560A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides |
| 07/01/1992 | EP0492500A2 Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP |
| 07/01/1992 | EP0492277A2 Cephalosporin derivatives |
| 07/01/1992 | EP0492136A2 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/01/1992 | EP0491956A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
| 07/01/1992 | EP0491873A1 Therapeutic compositions; methods for treatment of hiv infections |
| 07/01/1992 | EP0491793A1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
| 07/01/1992 | EP0491751A1 Antiviral tetrahydroimidazo 1,4]benzodiazepines |
| 06/30/1992 | US5126506 2',3'-Dideoxy-2'-fluoronucleosides |
| 06/30/1992 | US5126445 Process for the preparation of cefodizime sodium |
| 06/30/1992 | US5126436 Antibiotics |
| 06/30/1992 | US5126359 Fungicides |
| 06/30/1992 | US5126347 Autoimmune deficiency syndrome |
| 06/30/1992 | US5126336 Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| 06/30/1992 | US5126265 Ab-021 antibiotics and process for producing them |
| 06/30/1992 | US5126149 Tellurium tetrahalide for treament of autoimmune deficiency syndrome |
| 06/30/1992 | US5126127 Stabilized PVP-I solutions |
| 06/30/1992 | CA1304385C2 Process for producing tetramic acid |
| 06/30/1992 | CA1304360C Use of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2', 3'-didehydrocytidine) in treating patients infected with retroviruses |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/25/1992 | WO1992011258A1 Thiangazole, its preparation, compositions and use thereof |
| 06/25/1992 | WO1992010517A1 Tetrapeptides deriving from dalbaheptide antibiotics |
| 06/25/1992 | WO1992010513A1 Subunit papillomavirus vaccine and peptides for use therein |
| 06/25/1992 | WO1992010497A1 ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES |
| 06/25/1992 | WO1992010493A1 Polymorphs of crystalline mupirocin |
| 06/25/1992 | WO1992010492A1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 06/25/1992 | WO1992010191A1 Quinoline, naphthyridine and pyridobenzoxazine derivatives |
| 06/25/1992 | WO1992007564A3 Method of treating demyelinating disease |
| 06/25/1992 | DE4041304A1 Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren Of structural proteins of the hepatitis C virus-derived polypeptides, test kits containing such polypeptides, and vaccines against infection by hepatitis C virus |
| 06/25/1992 | CA2590125A1 Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
| 06/25/1992 | CA2098107A1 Polymorphs of crystalline mupirocin |
| 06/25/1992 | CA2097594A1 Thiangazole, its preparation, compositions and use thereof |
| 06/25/1992 | CA2057761A1 Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens hrpii and serp, the preparation and use thereof |
| 06/24/1992 | EP0491644A2 Process for obtaining polymers with antiviral activity |
| 06/24/1992 | EP0491643A2 Process for obtaining polymers with antiviral activity |
| 06/24/1992 | EP0491628A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 06/24/1992 | EP0491218A1 Benzodiazepinones |
| 06/24/1992 | EP0491125A1 Vaccines against equine herpes viruses and their preparation |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 06/24/1992 | CN1062138A Synergism of hiv reverse transcriptase inhibitors |
| 06/23/1992 | US5124442 Process for preparing azt (3'-azido-3'-deoxy-thymidine) and related compounds |
| 06/23/1992 | US5124323 2-(quinoliniumalkyl and isoquinoliniumalkyl) phenyl carbapenem antibacterial agents |
| 06/23/1992 | US5124147 Mixture of antagonist to platelet activating factor and antibody |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
| 06/22/1992 | CA2055984A1 Synergistic effect of lantibiotics in combination with selected agents against gram negative bacteria |
| 06/21/1992 | CA2057972A1 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 06/21/1992 | CA2057777A1 Cephalosporin derivatives |
| 06/21/1992 | CA2057432A1 2-halogeno-oxetanocin a and phosphoric ester thereof |
| 06/20/1992 | WO1992011037A2 Targeting of therapeutic agents using polysaccharides |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/19/1992 | CA2057821A1 Anti-herpes castanospermine esters |